Suzanne Amery
Papers
2
Total Citations
5
H-Index
1
About
Suzanne Amery is a clinical researcher whose work is reshaping the management of muscle-invasive bladder cancer (MIBC). Her primary focus lies in optimizing surgical outcomes for radical cystectomy (RC) and refining patient selection for bladder-sparing strategies. In her landmark 2025 study, Amery identified key predictors of adverse pathological upstaging in patients with clinical T2 MIBC undergoing RC, providing critical data to guide decisions between immediate surgery and trimodality therapy. Her analysis of over 200 cases from a single UK tertiary centre has already garnered 4 citations, underscoring its immediate relevance. Amery has also tackled the contentious issue of urethrectomy timing, comparing perioperative and survival outcomes between delayed and concomitant procedures in patients with non-metastatic urothelial carcinoma. Her findings offer evidence-based clarity on a practice that varies widely across institutions. By leveraging retrospective cohort data with rigorous statistical methods, Amery is building a foundation for more personalized, risk-stratified care in urologic oncology. Her work is essential reading for surgeons and oncologists navigating the complex trade-offs between aggressive resection and organ preservation.
Research Focus
Key Achievements
Top Papers
- 1
- 2